• Product NameLevosimendan
• Brief DescriptionInhibitors
• Purification99.91%
• Biological ActivityLevosimendan is a calcium sensitizer acting through calcium-dependent binding to cardiac troponin C (cTnC), provides treatment for heart failure.
• Target NameCarbonic Anhydrase inhibitor
• CAS No. 141505-33-1
• Calculated MW 280.28
• Formulation C14H12N6O
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cardiovascular System
  SMILES:C[C@@H]1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N
  Pathways:Metabolism
  Receptor:Cardiac troponin C
  Boling pt:
  Melting pt:216-219C
  Solubility:DMSO: 56 mg/mL (199.8 mM)
  Appearance:Yellow Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Haikala H, J Mol Cell Cardiol, 1995, 27(9), 1859-1866.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting